The One Big Beautiful Bill Act was signed into law on July 4, 2025. For compliance professionals tracking its impact on consumer financial regulation, the legislation's effects are a mix of significant structural changes, notable rejections of proposed provisions, and modest adjustments to existing regulatory frameworks.

Understanding what the bill actually did — as distinct from what was proposed and rejected — is essential for accurate compliance planning.

CFPB Funding Cap

The most significant structural change for the CFPB was the reduction of its annual funding cap. The bill reduced the maximum annual transfer from the Federal Reserve from 12 percent of the Federal Reserve's 2009 operating expenses to 6.5 percent. Adjusted for inflation, this limits fiscal year 2026 CFPB funding transfers to approximately $466.8 million — substantially below the agency's stated operational requirements.

The practical effect is a structurally constrained CFPB regardless of who leads it. The agency cannot spend more than the funding cap allows, and the reduction forces prioritization that would not have been necessary under the prior cap. The CFPB's restructuring plan — projecting 64 examinations in 2026 compared to 107 in 2024 — reflects this constraint.

What Was Proposed and Rejected — The State AI Preemption Moratorium

One of the most discussed provisions of the bill's legislative journey never made it into the final text. Senator Ted Cruz proposed a ten-year moratorium on state and local AI regulation as an amendment. The Senate voted 99 to 1 to strip the provision from the bill.

That vote is not a procedural footnote. It is a definitive statement from a bipartisan Senate supermajority that state AI governance laws — including TRAIGA and Colorado's AI Act — should not be preempted by federal action at this time. The moratorium's rejection is cited by state AI law proponents as the strongest available evidence that federal preemption is not a viable path for the foreseeable future.

Consumer Protection Provisions

The bill made several targeted changes to consumer financial protection frameworks. Most significant for the consumer reporting industry was the interaction between the bill's provisions and the CFPB's concurrent rulemaking activity. Several CFPB rules that were in the proposal or final stages at the time of the bill's enactment face questions about their legal authority under the adjusted funding and governance structure.

The CFPB's medical debt credit reporting rule, which would have prohibited reporting of medical debt on consumer credit reports, was subject to Congressional Review Act action. The rule's status remains uncertain as of April 2026.

What Did Not Change

The substantive text of the FCRA, FDCPA, TCPA, and HIPAA was not amended by the One Big Beautiful Bill Act. The private rights of action under those statutes remain intact. State consumer protection laws that are not preempted by those statutes remain in effect. The statutory obligations that generate most consumer financial services litigation have not changed.

The error compliance professionals should avoid is assuming that changes to the CFPB's enforcement posture represent changes to the underlying law. The law is the same. The enforcement environment has shifted. The distinction matters for compliance program design.

This article is for informational purposes and does not constitute legal advice.